Arch Therapeutics Inc (ARTH)

[21money21]

Ok, so we all know vagueness, the delays and lack of info is the reason this stock has declined. If their update on June 6 is vague and doesn't have much substance like a solid timeline they will punish Arth even more and it could get ugly.on the other hand, I don't think many are expecting too much in update either, ,so if they do come through with a nice solid update like a statement saying 510k will be applied for by end of July we could get a nice bump and start our assent. I believe in the product so fingers crossed for a big positive to come. Near term there will be a big swing either way imo. Gl longs